Defining the Risk of Ventricular Tachycardia in Genetic Cardiomyopathies
Part of paid clinical trials in Nashville, Tennessee.
- Sponsor
- Vanderbilt University Medical Center
- Study ID
- NCT06575881
- Status
- Recruiting
Conditions
- Atrial Fibrillation
- Premature Ventricular Contraction
- Ventricular Tachycardia
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The goal of this observational study is to determine if electrophysiologic mapping and cardiac MRI can help identify patients that have genetic forms of cardiomyopathy that are at high risk for development of dangerous ventricular arrhythmias. The investigators aim to study: 1. the prevalence and mechanism of inducible ventricular tachycardia 2. pace-mapping to define the site of origin of ventricular arrhythmias 3. voltage mapping to define low voltage scar substrate in the basal LV to determine the risk of development of ventricular arrhythmias in patients with genetic forms of cardiomyopathy. Participants will undergo cardiac MRI before their scheduled procedure and voltage mapping during their scheduled procedure as part of data collection.
Key Dates
- Start date
- Dec 13, 2023
- Status verified
- Apr 2026
- Primary completion
- Dec 31, 2028
- Completion
- Dec 31, 2029
Study Design
- Enrollment
- 200 participants (estimated)
Arms
- Arm: TTN-positivePatients with a pathogenic or likely pathogenic variant in TTN on clinical genetic testing.
- Arm: Gene-positivePatients with a pathogenic or likely pathogenic variant in a gene other than TTN on clinical genetic testing.
- Arm: Gene-negativePatients without a pathogenic or likely pathogenic variant in a cardiomyopathy or arrhythmia gene on clinical genetic testing.
Primary Outcome Measure
Ventricular Tachycardia Inducibility [ Time Frame: During procedure ]
Central Contacts
- Dakota Graherr, RN615-936-6069
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | - |
Find similar trials in Nashville, TN
Related Studies
- Anticoagulation in ICH Survivors for Stroke Prevention and RecoveryPHASE3 · Recruiting · Yale University · Birmingham, Alabama
- IVTCC 2.0: A Prospective Multicenter Ventricular Tachycardia Catheter Ablation RegistryEnrolling By Invitation · University of California, Los Angeles · Phoenix, Arizona
- Tracking Results of Ablations to Combat AF Registry Generation 2Recruiting · AtriCure, Inc. · Huntsville, Alabama
- The CONFORM Pivotal TrialRecruiting · Conformal Medical, Inc · Birmingham, Alabama